Show simple item record

A new approach for development of vaccine against visceral leishmaniasis: Lipophosphoglycan and polyacrylic acid conjugates

dc.contributor.authorAllahverdiyev, A.M.
dc.contributor.authorCakir, Koc, R.
dc.contributor.authorBagirova, M.
dc.contributor.authorElcicek, S.
dc.contributor.authorBaydar, S.Y.
dc.contributor.authorOztel, O.N.
dc.contributor.authorAbamor, E.S.
dc.contributor.authorAtes, S.C.
dc.contributor.authorTopuzogullari, M.
dc.contributor.authorIsoglu, Dincer, S.
dc.contributor.authorAkdeste, Z.
dc.date.accessioned2021-12-21T08:41:14Z
dc.date.available2021-12-21T08:41:14Z
dc.date.issued2017
dc.identifier.issn19957645
dc.identifier.urihttps://doi.org/10.1016/j.apjtm.2017.09.001
dc.identifier.urihttp://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1363
dc.description.abstractObjective To determine the antileishmanial vaccine effectiveness of lipophosphoglycan (LPG) and polyacrylic acids (PAA) conjugates on in vivo mice models. Methods LPG molecule was isolated and purified from large-scale Leishmania donovani parasite culture
dc.description.sponsorshipFoundation project: It is financially supported by TUBITAK ( 1085170SBAG–4007 ).
dc.language.isoEnglish
dc.publisherElsevier (Singapore) Pte Ltd
dc.rightsAll Open Access, Gold
dc.titleA new approach for development of vaccine against visceral leishmaniasis: Lipophosphoglycan and polyacrylic acid conjugates
dc.typeArticle
dc.relation.journalAsian Pacific Journal of Tropical Medicine
dc.identifier.issue9
dc.identifier.startpage877
dc.identifier.endpage886
dc.identifier.volume10
dc.identifier.doi10.1016/j.apjtm.2017.09.001
dc.relation.issue9
dc.relation.volume10


Files in this item

Thumbnail
Name:
1-s2.0-S1995764516304941-main.pdf
Size:
620.8Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record